DR. REDDY’S LABORATORIES LIMITED (RDY)

11.97USD -0.50% (-0.06)

Over 1M: -2.0%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

12 12.2 12.4
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Annual

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
FY23 — Revenue: 3B FY23 — Operating Cash Flow: 716M FY23 — Free Cash Flow: 578M FY23 — Net Income: 548M FY24 — Revenue: 3.4B FY24 — Operating Cash Flow: 545M FY24 — Free Cash Flow: 348M FY24 — Net Income: 668M FY25 — Revenue: 3.8B FY25 — Operating Cash Flow: 545M FY25 — Free Cash Flow: 223M FY25 — Net Income: 671M 0 800M 1.6B 2.4B 3.2B 4B
FY23 FY24 FY25
Revenue Operating Cash Flow Free Cash Flow Net Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

5.1
SBC / sales 0.13%
Oper. margin 22.1%
ROIC 15.6%
OE margin 5.7%
ROA 11.6%
ROCE 19.8%
Gross margin 58.5%
ROE 17.2%
Accruals 2.2%
FCF margin 5.9%
OCF margin 14.3%
OCF / EBIT 0.65×

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

7.1
EV/EBIT 12.3×
EV/OE 47.6×
P/E 14.9×
EV/GP 4.6×
EV/Sales 2.7×
P/B 2.6×
Div. yield 0.78%
FCF yield 2.2%
P/C 58.2×
Fwd P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

7.3
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

7.7
ND/EBITDA -0.035
Debt / Eq 0.14×
Net debt / Eq 0.094×
Payout 11.6%
Debt payback 1.6 yr
Quick ratio 1.4×
Cash / Debt 0.32×
F-score 2.0 pts
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.6
Sales/sh Y/Y +13.7%
Sales CAGR 4Y +10.1%
Shares change +0.077%
EBIT CAGR +26.2%
EPS Y/Y +0.37%
Div. growth -2.5%
EBIT Y/Y +3.6%
EPS CAGR 4Y —
EPS next Y —
Sales Q/Q —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.